advanced EGFR-mutated NSCLC, resistance to third-generation EGFR TKIs, the superiority of concurrent versus sequential therapy from the FLAURA2 study, the role of ctDNA in managing additional EGFR mutations, and decision-making in utilizing FLAURA2 for treatment...
FDA has approved paclitaxel protein-bound particles for injectable suspension) (albumin-bound) (Abraxane, Celgene) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), in combination with carboplatin, in patients who are not candidates fo...
“Key Updates and Practice-Changing Data for Advanced NSCLC” [non—small cell lung cancer],” I am joined by an international panel of experts in lung cancer clinical research. Today we will discuss the key studies that will impact the way you treat your patients, including updates from the...
Despite the availability of different treatmentsfor advanced NSCLC, all of them have a palliative intention and a cure for the disease is unlikely. Thus, advanced lungcancer remains as an unmet medical need.Chemotherapy has been used as the therapy of choice for advanced NSCLC patients,but it ...
Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), & Adva
For example, platinum-based chemo -- the kind used for advanced NSCLC -- damages all your fast-growing cells, even the healthy ones. Common side effects are: Nausea Diarrhea Hair loss Anemia Bleeding Chemo also can cause liver and kidney damage. If your side effects are severe, you may ne...
HONG KONG, Oct. 20, 2022 /PRNewswire/ -- Akeso's Ivonescimab (PD-1/VEGF BsAbs) Granted Breakthrough Therapy Designation by China NMPA for the Treatment of Advanced NSCLC
First-time data from a Phase 2 study conducted in China, independently led by Kelun-Biotech, evaluating sac-TMT in combination with KL-A167 (a PD-L1 antibody) as first-line treatment for advanced NSCLC (Abstract #8502; Lung Cance...
advanced recurrent NSCLC.Methods:The study was conducted on nineteen patients with advanced NSCLC who had failed to previous chemotherapy and all these patients had been confirmed with pathology or cytology.Among the 19 cases,9 cases were male and 10 were female,the median age was 48 years old,...
Research published in the February edition of theJournal of Thoracic Oncologysought to assess the overall efficacy of split-course palliative chest radiotherapy (RT) for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen's ...